Exacerbation of Multiple Sclerosis by BRAF/MEK Treatment for Malignant Melanoma: The Central Vein Sign to Distinguish Demyelinating Lesions From Metastases

• मुख्य लेखकों: Christopher C. Hemond MD (लेखक), Rohit Bakshi MD, MA (लेखक), Shahamat Tauhid MD (लेखक), Rosila Sarrosa (लेखक), Madison Ryan (लेखक), Vineetha Kamath (लेखक), James Thomas MD (लेखक), Keith R. Edwards MD (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: SAGE Publishing, 2021-07-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

The emergence of immunomodulators as effective cancer treatments has been an important advance in cancer therapy. The combination therapy of BRAF/MEK inhibition with or without anti-CTLA-4 treatment causes an immunostimulatory effect that has greatly reduced death from melanoma. In this article, we...